Exenatide treatment reduces serum irisin in type 2 diabetes patients.
This study investigated the effects of exenatide treatment on serum irisin levels in patients with type 2 diabetes mellitus (T2DM), finding a significant decline in irisin levels.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study investigated the effects of exenatide treatment on serum irisin levels in patients with type 2 diabetes mellitus (T2DM), finding a significant decline in irisin levels.
This study evaluated a KAP-based outdoor exercise education program for adults with Type 2 Diabetes compared to traditional exercise guidance. Results showed no significant differences in HbA1c or body weight, but improved exercise adherence in the KAP group.
This study analyzed the impact of behavioral physical activity interventions on gestational diabetes outcomes, revealing unclear effectiveness.
This study evaluated the effectiveness of hybrid closed-loop glucose control using faster-acting insulin aspart (Fiasp) in adults with type 1 diabetes. It found that Fiasp reduced the time spent with low glucose levels compared to standard insulin aspart.
Bariatric surgery, specifically gastric bypass and sleeve gastrectomy, improved beta-cell function in obese patients with type 2 diabetes.
This study analyzed the impact of dietary fiber intake on clinical outcomes in patients with Type 2 diabetes, revealing positive associations with various health metrics.
This study evaluated the effects of daily intake of freeze-dried kale powder on health in patients with type 2 diabetes, finding significant reductions in HbA1c and insulin resistance.
This study evaluated the efficacy and safety of benfotiamine in treating diabetic sensorimotor polyneuropathy. Results indicated no significant differences between benfotiamine and placebo groups.
This pilot study evaluated the combination of dulaglutide and a low energy diet in individuals with type 2 diabetes and obesity, finding significant weight loss and HbA1c reduction.
Nimba-Amalakyadi formulation compared to metformin in adults with type 2 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.